Jesse N. Aronowitz, M.D.

Graduate School

1977 M.D. Hahnemann Medical College


1990 - 1993 Manitoba Cancer Treatment and Research Foundation
1978 - 1980 East Carolina University


1980 American Board of Radiology

Academic Appointment

Associate Professor

Peer Reviewed Journal Papers

  • Aronowitz JN, Robison R. Howard A. Kelly establishes gynecologic brachytherapy in the United States. Brachytherapy In press
  • Aronowitz JN. Donald Lawrence and the ‘k-capture’ revolution. Brachytherapy In press
  • Aronowitz JN, Gay HA, Clark TJ, Helvecio M, Bushe H. Identification and management of persistently active brachytherapy ‘seed’ implants. Am J Roentgenol 2009;193:W403-406.
  • Aronowitz JN, Connock G, Haq R, Morin MJ. Radiation exposure from permanent prostate brachytherapy without fluoroscopy. Nowotwory J Oncol 2009;59:91e-93e.
  • Aronowitz JN, Michalski JM, Merrick GS, Sylvester JE, Crook JM, Butler WM. Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy. Am J Clin Oncol. In press.
  • Aronowitz JN. ‘Benign Essential Prostate Cancer’? Am J Clin Oncol 2009;32:224-225.
  • Aronowitz JN, Crook JM, Michalski JM, Sylvester JE, Merrick GS, Mawson C, Pratt D, Naidoo D, Butler WM, Karolczuk K. Inter-institutional variation of implant activity for permanent prostate brachytherapy. Brachytherapy 2008;7:297-300.
  • FitzGerald TJ, Wang T, Goel HL, Huang J, Stein G, Lian J, Davis RJ, Doxsey S, Balaji KC, Aronowitz J, Languino LR. Prostate carcinoma and radiation therapy: Therapeutic treatment resistance and strategies for targeted therapeutic intervention. Expert Rev Anticancer Ther. 2008;8:967-974.
  • Aronowitz JN. The ‘Golden Era’ of prostate brachytherapy; a cautionary tale. Brachytherapy 2008;7:55-59.
  • FitzGerald TJ, Jodoin MB, Tillman G, Aronowitz J, Pieters R, Balducci S, Meyer J, Cicchetti MG, Kadish S, McCaughley S, Sawicka J, Urie M, Lo YC, Mayo C, Ulin K, Ding L, Britton M, Huang J, Arous E. Radiation therapy toxicity to the skin. Dermatol Clin 2008;26:161-172.
  • Mould RF, Aronowitz JN, Van Tiggelen, Litten FS. Cancer Journals 1853-1934. Nowotwory J Oncol 2007; 57: 195e-201e.
  • Aronowitz JN, Aronowitz SV, Robison R. Classics in Brachytherapy: Margaret Cleaves introduces gynecologic brachytherapy. Brachytherapy 2007;6:293-297.
  • Mould RF, Litten FS, Bruggmoser G, Aronowitz J. Proposals for radium therapy in 1903. Nowotwory J Oncol 2007; 57:136-138.
  • Mould RF, Aronowitz JN. Evolution of the knowledge of electricity and electrotherapeutics with special reference to X-rays and cancer Part 3. Nowotwory J Oncol 2007; 57:82-92.
  • Aronowitz JN. Ethereal Fire: Antecedents of radiology and radiotherapy. Am J Roentgenol 2007;188:904-912.
  • Mould RF, Aronowitz JN. Evolution of the knowledge of electricity and electrotherapeutics with special reference to X-rays and cancer Part 2. Nowotwory J Oncol 2007; 57:24-33.
  • Pohar S, Haq R, Liu L, Koniarczyk M, Hahn S, Damron T, Aronowitz JN. Adjuvant high and low dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: A comparison of outcomes. Brachytherapy 2007; 6:53-57.
  • Mould RF, Aronowitz JN. Evolution of the knowledge of electricity and electrotherapeutics with special reference to X-rays and cancer Part 1. Nowotwory J Oncol 2006; 56:653-662.
  • Aronowitz JN, Pohar SS, Liu L, Damron TA. Adjuvant high dose rate brachytherapy in the management of soft tissue sarcoma: A dose-toxicity analysis. Am J Clin Oncol 2006; 29:508-513.
  • Aronowitz JN, Liu L, Haq R, Pohar S. Matched peripheral dose & dose-volume histograms: Fusing an old concept with modern technology for brachytherapy prescription. Nowotwory J Oncol 2006; 56: 385-388.
  • Aronowitz JN, Bruggmoser G. Prostate brachytherapy in 1909. Nowotwory J Oncol 2006;56:410-412.
  • FitzGerald TJ, Aronowitz J, Cicchetti MG, Fisher G, Kadish S, Lo YC, Mayo C, McCauley S,Meyer J, Pieters R, Sherman A. The effect of radiation therapy on normal tissue. Hematol Oncol Clin North Am 2006; 20:141-163.
  • Merrick GS, Butler WM, Wallner KE, Blasko JC, Michalski J, Aronowitz J, Grimm P, Moran BJ, McLaughlin PW, Usher J, Lief JH, Allen ZA. Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis. Brachytherapy 2006;4:241-251.
  • Bogart JA, Aronowitz JN. Localized non-small cell lung cancer: Adjuvant radiotherapy in the era of effective systemic therapy. Clin Cancer Res 2005;11:5004s-5010s.
  • Bogart JA, Alpert TE, Kilpatrick MC, Keshler BL, Pohar SS, Shah H, Dexter E, Aronowitz JN. Dose-intensive thoracic radiation therapy for high risk patients with early-stage non-small-cell lung cancer. Clin Lung Cancer 2005;6(6):350-354.
  • Aronowitz J, Follette J, Moran MJ. Does anesthesia method impact implant-induced prostate swelling? Urology 2005; 65:513-516.
  • Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Critical evaluation of Mirel’s rating system for impending pathologic fractures. Clin Ortho Rel Res 2003; 415S:S201-207.
  • Aronowitz J. Buried Emanation: The development of seeds for permanent implantation. Brachytherapy 2002; 1:167-178.
  • Aronowitz J. Dawn of prostate brachytherapy: 1915-1930. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):712-8.
  • Aronowitz J. Benjamin Barringer: originator of the transperineal prostate implant. Urology. 2002; 60(4):731-4.
  • Aronowitz J., Schwartz J., Moran MJ. In regard to Sherertz et al. Int J Radiat Oncol Biol Phys. 2002; 53(4):1087.
  • Aronowitz J, Baral E. Dalal BI. Late transition of hairy cell leukemia to multiple myeloma. Am J Hematol. 1993; 44(3):216-7.

Book Chapters

  • Damron T, Aronowitz J. Metastatic Disease of the Distal Humerus, Forearm, and Hand. Heiner J, Kinsella T, Zdeblick T (eds), Management of Metastatic Disease to the Musculo-skeletal System. Quality Medical Publishing, Inc. 493-509, 2002
  • Aronowitz J, Hahn P, Haas G. Radiation therapy: basic sciences. In: Belldegrun, et al (eds). Renal and Adrenal Tumors: Biology and Management. Oxford University Press. Chapter 37, 2002